ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

Bush Appoints Kripke To President’s Cancer Panel

February 21, 2003

FDA Designates Zometa For Priority Review.

November 30, 2001

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003